Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


Chemicals Sales & Marketing Toolbox 2014

03 Jun 2014 - 04 Jun 2014 - Berlin, Germany



Bookmark and Share


Evolve your business relationships and increase your profitability 

Chemical Sales & Marketing Toolbox 2014 will give the knowledge you need to improve your business by better adjusting to suit your customers' evolving needs.

Join the leading European cross-segment chemicals event. Learn to use the right tools, gain important business contacts, and find practical answers on the topics that matter most across every segment of the chemicals business.

These questions and many others will be answered at the event:

How can you open the door for a lasting relationship with your customers?

Which tools are the most effective to build a highly successful international sales team?

How can you satisfy your customers by structuring what you offer to suit their individual needs?

How to optimize profit opportunity in every deal?

How can you grasp opportunities that come with green transformation and shale gas discoveries?

Which tools should you use in a high-risk environment?

Today's reality for businesses involves the changing needs and requests of customers. You may be wondering how you can meet their specific needs while at the same time increasing your profitability.

This cross-segment chemicals event will bring together the European chemicals elite and will reveal concrete tools that will solve challenges like:

How to optimize profit opportunity in every deal?

How you can open the door for a lasting relationship with your customers?

Which tools are the most effective to build a highly successful international sales team?

How to use market analysis matrices to take advantage of opportunities to grow in EMEA and      emerging markets?

 To read the full PDF program fill out a short online form.




Further information
Scientific News
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Important Regulator of Immune System Decoded
Plasma cells play a key role in our immune system. Now scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria, and at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, succeeded in characterizing a central regulator of plasma cell function.
Bacterial Superglue for Faster Vaccine Development
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.
Enumeral, MD Anderson Enter Into Collaboration
Strategic collaboration aims to discover and develop potentially novel antibodies against specified targets for immunotherapy.
Joint venture for GlycoMar Limited and MicroA AS
Scottish biotechnology company GlycoMar and Norwegian technology company MicroA are pleased to announce their joint venture business Prasinotech Ltd. The new company is registered in Scotland.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!